Dr. Greg Durm
Claim this profileIndiana University/Melvin and Bren Simon Cancer Center
Studies Lung Cancer
Studies Squamous Cell Carcinoma
7 reported clinical trials
14 drugs studied
Area of expertise
1Lung Cancer
Stage I
PD-L1 positive
PD-L1 negative
2Squamous Cell Carcinoma
Stage III
Stage IV
HPV negative
Affiliated Hospitals
Clinical Trials Greg Durm is currently running
Radiation Therapy + Cisplatin
for Head and Neck Cancer
This trial is studying if using a specific type of energy treatment alone or with a drug is better for treating patients with advanced head and neck cancer after surgery. The energy treatment kills cancer cells, and the drug helps by stopping their growth or killing them. The drug has been used for many years in the treatment of advanced cancers, including head and neck cancers, and is known for its ability to enhance the effects of the energy treatment.
Recruiting1 award Phase 219 criteria
Pembrolizumab
for Early-Stage Non-Small Cell Lung Cancer
A randomized trial of adjuvant Pembrolizumab following surgical resection versus observation following surgical resection in patients with stage I non-small cell lung cancer (NSCLC) with primary tumors between 1-4 cm. Patients will be randomized (1:1) 4-12 weeks following surgery to either: * Arm A: Pembrolizumab 400 mg every 6 weeks × 9 cycles * Arm B: Observation Stratification factors will include: PD-L1 TPS (\<50% vs. ≥50%), and tumor size (1-2 cm vs. \>2-4 cm)
Recruiting1 award Phase 25 criteria
More about Greg Durm
Clinical Trial Related6 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Greg Durm has experience with
- Nivolumab
- Cisplatin
- Intensity-Modulated Radiation Therapy
- Pembrolizumab
- Ipilimumab
- BI 754091
Breakdown of trials Greg Durm has run
Lung Cancer
Squamous Cell Carcinoma
Throat Cancer
Oropharyngeal Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Greg Durm specialize in?
Greg Durm focuses on Lung Cancer and Squamous Cell Carcinoma. In particular, much of their work with Lung Cancer has involved Stage I patients, or patients who are PD-L1 positive.
Is Greg Durm currently recruiting for clinical trials?
Yes, Greg Durm is currently recruiting for 2 clinical trials in Indianapolis Indiana. If you're interested in participating, you should apply.
Are there any treatments that Greg Durm has studied deeply?
Yes, Greg Durm has studied treatments such as Nivolumab, Cisplatin, Intensity-Modulated Radiation Therapy.
What is the best way to schedule an appointment with Greg Durm?
Apply for one of the trials that Greg Durm is conducting.
What is the office address of Greg Durm?
The office of Greg Durm is located at: Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis, Indiana 46202 United States. This is the address for their practice at the Indiana University/Melvin and Bren Simon Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.